Context Overdiagnosis as the argument to stop prostate cancer (PCa) screening is less valid
since the introduction of new technologies such as risk calculators (RCs) and magnetic …

Purpose Magnetic resonance imaging (MRI) has deeply altered the prostate biopsy strategy
to detect prostate cancer. However, it is still debatable whether the detection rate differs …

Context It is unclear whether a magnetic resonance imaging (MRI)-targeted transperineal
(TP) biopsy can improve the detection of clinically significant prostate cancer (csPCa) …

Purpose: Our aim was to evaluate whether transperineal (TP) MRI-targeted prostate biopsy
(TBx) may improve the detection of clinically significant prostate cancer (csPCa), defined as …

Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Background There is large variability among radiologists in their detection of clinically
significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging …

Background Currently, transperineal prostate biopsy (TPB) is preferred over transrectal
biopsy (TRB) because of less infectious complications and improved clinically significant …

Background Transperineal magnetic resonance imaging–transrectal ultrasound fusion
guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of …

Objective To address the limitations and challenges associated with transrectal (TR) biopsy
and to present transperineal (TP) biopsy as a viable and potentially safer alternative to TR …

Background Recent guidelines favor transperineal (TP) prostate biopsies over the
transrectal (TR) approach due to a reduced sepsis risk. Yet, evidence from controlled trial …